Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Energy Intake | 14 | 2021 | 74 | 2.830 |
Why?
|
| Sarcopenia | 8 | 2021 | 29 | 2.490 |
Why?
|
| Intensive Care Units | 16 | 2021 | 246 | 2.380 |
Why?
|
| Enteral Nutrition | 13 | 2021 | 57 | 2.320 |
Why?
|
| Parenteral Nutrition | 10 | 2021 | 20 | 2.310 |
Why?
|
| Nutritional Status | 14 | 2021 | 54 | 2.310 |
Why?
|
| Critical Care | 8 | 2021 | 112 | 2.240 |
Why?
|
| Critical Illness | 17 | 2021 | 106 | 2.180 |
Why?
|
| Malnutrition | 9 | 2019 | 24 | 2.140 |
Why?
|
| Nutritional Support | 8 | 2021 | 23 | 1.970 |
Why?
|
| Acute Lung Injury | 6 | 2018 | 18 | 1.640 |
Why?
|
| Body Composition | 6 | 2022 | 62 | 1.530 |
Why?
|
| Dietetics | 5 | 2020 | 9 | 1.520 |
Why?
|
| Hypothyroidism | 3 | 2023 | 69 | 1.210 |
Why?
|
| Respiratory Insufficiency | 6 | 2023 | 46 | 1.090 |
Why?
|
| Humans | 58 | 2023 | 24703 | 1.080 |
Why?
|
| Nutritional Requirements | 7 | 2021 | 16 | 1.050 |
Why?
|
| Neoplasms | 3 | 2017 | 213 | 1.000 |
Why?
|
| Respiratory Muscles | 3 | 2021 | 18 | 0.970 |
Why?
|
| Muscle, Skeletal | 7 | 2021 | 369 | 0.950 |
Why?
|
| Blood Glucose | 6 | 2021 | 93 | 0.940 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2022 | 613 | 0.920 |
Why?
|
| Hand Strength | 2 | 2021 | 53 | 0.860 |
Why?
|
| Male | 37 | 2022 | 13669 | 0.810 |
Why?
|
| Female | 37 | 2022 | 14048 | 0.800 |
Why?
|
| Research Design | 2 | 2021 | 172 | 0.750 |
Why?
|
| Nutrition Assessment | 8 | 2019 | 42 | 0.720 |
Why?
|
| Thyroxine | 4 | 2023 | 81 | 0.710 |
Why?
|
| Nutritionists | 2 | 2020 | 2 | 0.700 |
Why?
|
| C-Reactive Protein | 4 | 2016 | 95 | 0.690 |
Why?
|
| Adult | 22 | 2023 | 7255 | 0.680 |
Why?
|
| Hospitalization | 7 | 2018 | 286 | 0.670 |
Why?
|
| Medical Staff Privileges | 1 | 2020 | 2 | 0.670 |
Why?
|
| Cachexia | 2 | 2017 | 10 | 0.660 |
Why?
|
| Prescriptions | 1 | 2020 | 16 | 0.660 |
Why?
|
| Middle Aged | 26 | 2021 | 8294 | 0.640 |
Why?
|
| Muscle Strength | 2 | 2019 | 123 | 0.640 |
Why?
|
| Cross-Sectional Studies | 7 | 2023 | 807 | 0.620 |
Why?
|
| Insulin | 4 | 2013 | 82 | 0.610 |
Why?
|
| Organ Dysfunction Scores | 1 | 2019 | 5 | 0.610 |
Why?
|
| Triiodothyronine | 3 | 2023 | 92 | 0.580 |
Why?
|
| Underage Drinking | 1 | 2017 | 1 | 0.550 |
Why?
|
| Thyrotropin | 2 | 2020 | 49 | 0.550 |
Why?
|
| Impulsive Behavior | 1 | 2017 | 14 | 0.550 |
Why?
|
| Adolescent Behavior | 1 | 2017 | 23 | 0.540 |
Why?
|
| Dietary Proteins | 5 | 2016 | 26 | 0.540 |
Why?
|
| Prevalence | 8 | 2021 | 411 | 0.530 |
Why?
|
| Self Report | 1 | 2018 | 199 | 0.530 |
Why?
|
| Personality | 1 | 2017 | 51 | 0.530 |
Why?
|
| Retrospective Studies | 10 | 2021 | 3156 | 0.510 |
Why?
|
| Smoking | 1 | 2017 | 172 | 0.500 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 304 | 0.470 |
Why?
|
| Respiration, Artificial | 8 | 2021 | 101 | 0.450 |
Why?
|
| Aged | 20 | 2021 | 8382 | 0.450 |
Why?
|
| Hypoglycemia | 1 | 2013 | 12 | 0.400 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2011 | 3 | 0.370 |
Why?
|
| Prealbumin | 1 | 2011 | 4 | 0.370 |
Why?
|
| APACHE | 6 | 2021 | 27 | 0.360 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 64 | 0.350 |
Why?
|
| Eating | 1 | 2010 | 48 | 0.320 |
Why?
|
| Quality of Health Care | 1 | 2010 | 91 | 0.320 |
Why?
|
| Inflammation | 1 | 2011 | 258 | 0.320 |
Why?
|
| Patient Care Team | 1 | 2010 | 105 | 0.310 |
Why?
|
| Body Mass Index | 7 | 2022 | 421 | 0.300 |
Why?
|
| Diet | 1 | 2010 | 192 | 0.300 |
Why?
|
| Adipose Tissue | 2 | 2022 | 71 | 0.280 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 244 | 0.280 |
Why?
|
| Hospital Mortality | 3 | 2017 | 121 | 0.280 |
Why?
|
| Affect | 2 | 2018 | 57 | 0.270 |
Why?
|
| Surveys and Questionnaires | 4 | 2023 | 1042 | 0.270 |
Why?
|
| Hyperglycemia | 4 | 2013 | 25 | 0.250 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 278 | 0.250 |
Why?
|
| Ketone Bodies | 1 | 2005 | 3 | 0.240 |
Why?
|
| Growth | 1 | 2005 | 6 | 0.240 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2005 | 5 | 0.240 |
Why?
|
| Ketosis | 1 | 2005 | 7 | 0.240 |
Why?
|
| Obesity | 4 | 2016 | 280 | 0.230 |
Why?
|
| Epilepsy | 1 | 2005 | 68 | 0.220 |
Why?
|
| Child Development | 1 | 2005 | 69 | 0.220 |
Why?
|
| Pilot Projects | 3 | 2021 | 370 | 0.220 |
Why?
|
| Depression | 2 | 2018 | 390 | 0.220 |
Why?
|
| Length of Stay | 5 | 2014 | 294 | 0.210 |
Why?
|
| Proportional Hazards Models | 4 | 2017 | 303 | 0.210 |
Why?
|
| Risk Factors | 4 | 2021 | 2099 | 0.200 |
Why?
|
| Postoperative Complications | 2 | 2021 | 864 | 0.200 |
Why?
|
| Noninvasive Ventilation | 1 | 2023 | 11 | 0.200 |
Why?
|
| Inpatients | 2 | 2019 | 112 | 0.200 |
Why?
|
| Maximal Respiratory Pressures | 2 | 2019 | 3 | 0.200 |
Why?
|
| Academies and Institutes | 2 | 2020 | 11 | 0.200 |
Why?
|
| Physicians | 2 | 2018 | 103 | 0.190 |
Why?
|
| Societies, Medical | 2 | 2020 | 118 | 0.190 |
Why?
|
| Respiratory Function Tests | 2 | 2019 | 26 | 0.180 |
Why?
|
| Muscles | 1 | 2021 | 49 | 0.180 |
Why?
|
| Prospective Studies | 7 | 2020 | 1612 | 0.180 |
Why?
|
| Sample Size | 1 | 2021 | 17 | 0.180 |
Why?
|
| Child | 3 | 2018 | 1131 | 0.180 |
Why?
|
| Aged, 80 and over | 7 | 2016 | 4509 | 0.180 |
Why?
|
| Coma | 1 | 2021 | 5 | 0.180 |
Why?
|
| Delirium | 1 | 2021 | 12 | 0.170 |
Why?
|
| International Classification of Diseases | 2 | 2018 | 13 | 0.170 |
Why?
|
| Superoxide Dismutase | 1 | 2020 | 21 | 0.170 |
Why?
|
| Documentation | 2 | 2018 | 21 | 0.170 |
Why?
|
| Intersectoral Collaboration | 1 | 2020 | 6 | 0.170 |
Why?
|
| Euthyroid Sick Syndromes | 1 | 2020 | 7 | 0.160 |
Why?
|
| Cohort Studies | 4 | 2013 | 1748 | 0.160 |
Why?
|
| Long-Term Care | 1 | 2020 | 54 | 0.160 |
Why?
|
| Medicaid | 1 | 2020 | 32 | 0.160 |
Why?
|
| Muscular Atrophy | 2 | 2016 | 12 | 0.160 |
Why?
|
| Medicare | 1 | 2020 | 111 | 0.160 |
Why?
|
| Hospitals | 1 | 2020 | 149 | 0.150 |
Why?
|
| Adolescent | 3 | 2017 | 1992 | 0.150 |
Why?
|
| Patients | 1 | 2019 | 31 | 0.150 |
Why?
|
| Overweight | 2 | 2016 | 68 | 0.150 |
Why?
|
| Child Nutrition Disorders | 1 | 2018 | 1 | 0.150 |
Why?
|
| Clinical Coding | 1 | 2018 | 4 | 0.140 |
Why?
|
| Diagnosis-Related Groups | 1 | 2018 | 7 | 0.140 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2018 | 11 | 0.140 |
Why?
|
| Hormone Replacement Therapy | 1 | 2018 | 33 | 0.140 |
Why?
|
| Thyroid Gland | 1 | 2018 | 43 | 0.140 |
Why?
|
| Fatigue | 1 | 2018 | 45 | 0.140 |
Why?
|
| Professional Competence | 1 | 2018 | 38 | 0.140 |
Why?
|
| Emotions | 1 | 2018 | 72 | 0.140 |
Why?
|
| Puberty | 1 | 2017 | 10 | 0.140 |
Why?
|
| Hospital Costs | 1 | 2018 | 56 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2017 | 6 | 0.140 |
Why?
|
| Patient Compliance | 2 | 2016 | 144 | 0.140 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 17 | 0.140 |
Why?
|
| Internet | 1 | 2018 | 80 | 0.140 |
Why?
|
| Child Behavior | 1 | 2017 | 28 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 412 | 0.130 |
Why?
|
| Tomography | 2 | 2013 | 12 | 0.130 |
Why?
|
| Quality of Life | 2 | 2018 | 541 | 0.130 |
Why?
|
| Graft vs Host Disease | 1 | 2017 | 31 | 0.130 |
Why?
|
| Treatment Outcome | 5 | 2020 | 3208 | 0.130 |
Why?
|
| Thyroid Function Tests | 1 | 2016 | 12 | 0.130 |
Why?
|
| United States | 2 | 2020 | 1873 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 151 | 0.130 |
Why?
|
| Healthy Lifestyle | 1 | 2016 | 39 | 0.130 |
Why?
|
| Electric Impedance | 1 | 2016 | 24 | 0.130 |
Why?
|
| Health Surveys | 1 | 2016 | 84 | 0.130 |
Why?
|
| Quadriceps Muscle | 1 | 2016 | 33 | 0.130 |
Why?
|
| Point-of-Care Testing | 1 | 2016 | 27 | 0.130 |
Why?
|
| Cystic Fibrosis | 1 | 2016 | 9 | 0.120 |
Why?
|
| Case-Control Studies | 1 | 2017 | 555 | 0.120 |
Why?
|
| Liver Failure | 1 | 2015 | 10 | 0.120 |
Why?
|
| Advance Care Planning | 1 | 2016 | 11 | 0.120 |
Why?
|
| Dyspnea | 1 | 2016 | 35 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 315 | 0.120 |
Why?
|
| MEDLINE | 1 | 2015 | 4 | 0.120 |
Why?
|
| Palliative Care | 1 | 2016 | 104 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2016 | 202 | 0.110 |
Why?
|
| Diabetes Mellitus | 2 | 2013 | 113 | 0.110 |
Why?
|
| Comorbidity | 1 | 2015 | 447 | 0.110 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 37 | 0.110 |
Why?
|
| Chronic Disease | 1 | 2015 | 384 | 0.110 |
Why?
|
| Logistic Models | 3 | 2016 | 365 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1293 | 0.100 |
Why?
|
| Exercise | 1 | 2016 | 399 | 0.100 |
Why?
|
| Pain | 1 | 2016 | 382 | 0.100 |
Why?
|
| Nutrition Therapy | 1 | 2012 | 6 | 0.100 |
Why?
|
| Nausea | 2 | 2010 | 23 | 0.100 |
Why?
|
| Vomiting | 2 | 2010 | 18 | 0.100 |
Why?
|
| Geriatric Assessment | 1 | 2013 | 199 | 0.090 |
Why?
|
| Health Facilities | 1 | 2011 | 25 | 0.090 |
Why?
|
| Cost Savings | 1 | 2010 | 30 | 0.090 |
Why?
|
| Urban Population | 1 | 2011 | 141 | 0.080 |
Why?
|
| Cognition | 1 | 2018 | 1237 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 118 | 0.080 |
Why?
|
| Body Weight | 2 | 2014 | 128 | 0.080 |
Why?
|
| Liver | 1 | 2011 | 142 | 0.080 |
Why?
|
| Anorexia | 1 | 2010 | 3 | 0.080 |
Why?
|
| Drug Stability | 1 | 2010 | 3 | 0.080 |
Why?
|
| Drug Compounding | 1 | 2010 | 3 | 0.080 |
Why?
|
| Drug Monitoring | 1 | 2010 | 10 | 0.080 |
Why?
|
| Deglutition Disorders | 1 | 2010 | 30 | 0.080 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2010 | 11 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2020 | 94 | 0.080 |
Why?
|
| Precision Medicine | 1 | 2010 | 20 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2010 | 97 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 158 | 0.080 |
Why?
|
| Ventilator Weaning | 1 | 2010 | 30 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 54 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 250 | 0.080 |
Why?
|
| Chicago | 4 | 2019 | 858 | 0.080 |
Why?
|
| Patient Selection | 1 | 2010 | 177 | 0.070 |
Why?
|
| Biomarkers | 1 | 2011 | 520 | 0.070 |
Why?
|
| Nutritional Sciences | 1 | 2008 | 7 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2008 | 99 | 0.070 |
Why?
|
| Body Height | 1 | 2005 | 35 | 0.060 |
Why?
|
| Aging | 1 | 2013 | 1460 | 0.050 |
Why?
|
| Nutrition Surveys | 1 | 2023 | 23 | 0.050 |
Why?
|
| Demography | 1 | 2023 | 68 | 0.050 |
Why?
|
| Infant | 1 | 2005 | 482 | 0.050 |
Why?
|
| Cannula | 1 | 2023 | 7 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2005 | 567 | 0.050 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2023 | 13 | 0.050 |
Why?
|
| Thyroid Hormones | 1 | 2023 | 58 | 0.050 |
Why?
|
| Oxygen | 1 | 2023 | 59 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2021 | 24 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 27 | 0.040 |
Why?
|
| Glutathione Peroxidase | 1 | 2020 | 4 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 20 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 1671 | 0.040 |
Why?
|
| Triiodothyronine, Reverse | 1 | 2020 | 9 | 0.040 |
Why?
|
| Young Adult | 2 | 2016 | 1847 | 0.040 |
Why?
|
| Genotype | 1 | 2020 | 332 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2020 | 240 | 0.040 |
Why?
|
| Societies | 1 | 2018 | 6 | 0.040 |
Why?
|
| Consensus | 1 | 2018 | 86 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2018 | 65 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 117 | 0.030 |
Why?
|
| Injections, Subcutaneous | 2 | 2006 | 21 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 61 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 2006 | 51 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 60 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2016 | 78 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 131 | 0.030 |
Why?
|
| Terminal Care | 1 | 2016 | 23 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2016 | 37 | 0.030 |
Why?
|
| Medical Subject Headings | 1 | 2015 | 1 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2016 | 143 | 0.030 |
Why?
|
| Search Engine | 1 | 2015 | 5 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 81 | 0.030 |
Why?
|
| Age of Onset | 1 | 2014 | 89 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2014 | 12 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 598 | 0.030 |
Why?
|
| Chronic Pain | 1 | 2016 | 129 | 0.030 |
Why?
|
| Body Fluid Compartments | 1 | 2013 | 5 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2013 | 26 | 0.030 |
Why?
|
| Reference Values | 1 | 2013 | 174 | 0.030 |
Why?
|
| Minority Groups | 1 | 2013 | 67 | 0.030 |
Why?
|
| Lumbosacral Region | 1 | 2013 | 51 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 34 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 814 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2013 | 30 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 251 | 0.020 |
Why?
|
| General Surgery | 1 | 2013 | 38 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 199 | 0.020 |
Why?
|
| Sepsis | 1 | 2013 | 110 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 443 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2013 | 123 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 437 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2008 | 16 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 125 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 243 | 0.020 |
Why?
|
| Insulin Glargine | 1 | 2006 | 2 | 0.020 |
Why?
|
| Insulin, Long-Acting | 1 | 2006 | 2 | 0.020 |
Why?
|
| Insulin Infusion Systems | 1 | 2006 | 2 | 0.020 |
Why?
|
| Management Service Organizations | 1 | 2006 | 1 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2008 | 137 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2006 | 34 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2006 | 54 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 314 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2008 | 198 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2008 | 199 | 0.010 |
Why?
|
| Gastrointestinal Contents | 1 | 2004 | 2 | 0.010 |
Why?
|
| Gastric Emptying | 1 | 2004 | 12 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2004 | 30 | 0.010 |
Why?
|
| Algorithms | 1 | 2006 | 330 | 0.010 |
Why?
|
| Diarrhea | 1 | 2004 | 27 | 0.010 |
Why?
|